Delivery Order SPE2DB25D9305-SPE2DB26FQAAL
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,046.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. This firm fixed-price delivery order, issued on October 16, 2025, with an ultimate completion date of November 6, 2025, was awarded without set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- The Defense Logistics Agency awarded a delivery order valued at $2,436.88 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 ml vials. The contract is a firm fixed-price delivery order with an ultimate completion date of November 7, 2025, and was awarded on October 17, 2025. This award carries no set-aside designation, demonstrating the vendor's competitive capability in...
- The Defense Logistics Agency issued a firm fixed-price delivery order valued at $9,044.22 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. This delivery order, awarded on October 20, 2025, represents one of numerous pharmaceutical procurement actions issued to the vendor during October 2025. The award carries no set-aside designation, demonstrating DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order valued at $7,531.89 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on September 12, 2025, with an ultimate completion date of October 3, 2025, represents a discrete purchase under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA. The contract involves no...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,042.52 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 mL vials. This firm fixed-price delivery order, issued on September 26, 2025, with an ultimate completion date of October 20, 2025, carries no set-aside designation, indicating the award was made through full and open competition. The product will be delivered to...
- The Defense Logistics Agency awarded a $50,212.60 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for EXPAREL (liposomal bupivacaine) 266 mg/20 ml vials. The delivery order was issued on October 16, 2025, with an ultimate completion date of November 6, 2025, and carries no set-aside designation, indicating DMS Pharmaceutical Group competed successfully in unrestricted federal...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on August 4, 2025, for EXPAREL 133 mg/10 ml vials valued at $15,072.20. This firm fixed-price delivery order, which is not associated with a set-aside designation, is funded by the Defense Logistics Agency's Medical Supply Chain division and is scheduled for completion by August 25, 2025. The award leverages DMS Pharmaceutical Group's position as a...
- The Defense Logistics Agency awarded a delivery order valued at $12,553.15 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. This firm fixed-price delivery order, awarded on June 2, 2025, with completion targeted for June 24, 2025, represents a direct pharmaceutical supply requirement for federal healthcare operations. The award carries no set-aside designation, demonstrating...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $37,659.45 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 MG/20 ML vials. The contract, awarded on September 9, 2025, with an ultimate completion date of September 30, 2025, utilizes firm fixed-price pricing with no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of EXPAREL 266 mg/20 ml vials. The contract, awarded on September 24, 2025, carries a ceiling value of $15,063.78 and is structured as a firm fixed-price delivery order with an ultimate completion date of October 16, 2025. This award utilizes no set-aside designation, demonstrating the vendor's competitive...
- SPE2DB25D9305Indefinite Delivery Contract
- SPE2DB25D9305-SPE2DB26FQAALDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,046.10 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of EXPAREL 133 mg/10 mL vials. The award, issued on October 21, 2025, with an ultimate completion date of November 12, 2025, is structured as a firm fixed-price delivery order with no set-aside designation, indicating the vendor competed in unrestricted federal procurement. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) under the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to establish regional prime vendor contractors for recurring pharmaceutical supply needs across Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has demonstrated substantial federal contracting activity as a critical supplier within the military pharmaceutical supply chain, with numerous delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division. The company's established product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, with EXPAREL—a specialty surgical product used for local anesthesia—representing one component of its comprehensive offerings to support Department of Defense healthcare operations. The underlying PPV-G GEN V contract provides a ceiling value of $499,999,999 with an ultimate completion date of December 31, 2036, structured with a 30-month base period and three 30-month option periods to ensure sustained pharmaceutical supply capabilities for military medical facilities globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 10/21/25 |